erythromycin has been researched along with dalfopristin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lion, C; Lozniewski, A; Mory, F; Weber, M | 1 |
| Foustoukou, M; Ioannidou, S; Kotsovili-Tseleni, A; Legakis, NJ; Tassios, PT; Vatopoulos, A | 1 |
| Brandt, CM; Bryskier, A; Holland, R; Honscha, M; Hövener, B; Lütticken, R; Reinert, RR; Truong, ND | 1 |
| Cartwright, FD; Kenny, GE | 1 |
| Chang, FY; Chuang, YC; Hsueh, PR; Huang, WK; Ko, WC; Lau, YJ; Lee, CM; Leu, HS; Liu, CY; Liu, YC; Lu, JJ; Luh, KT; Shyr, JM; Teng, LJ; Wan, JH; Wu, JJ; Wu, TL; Yan, JJ; Yang, D; Yang, YC | 1 |
| Gfeller, KY; Meile, L; Roth, M; Teuber, M | 1 |
| Min, YH; Park, B | 1 |
7 other study(ies) available for erythromycin and dalfopristin
| Article | Year |
|---|---|
Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae; Virginiamycin | 2000 |
Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Greece; Humans; Infant; Male; Microbial Sensitivity Tests; Oropharynx; Phenotype; Rifampin; Streptococcus; Tetracycline; Vancomycin; Virginiamycin | 2001 |
Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.
Topics: Anti-Bacterial Agents; Drug Resistance; Erythromycin; Genotype; Germany; Ketolides; Macrolides; Microbial Sensitivity Tests; Pharynx; Phenotype; Polymorphism, Restriction Fragment Length; Regulon; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Streptococcal Infections; Streptococcus pyogenes; Streptogramins; Virginiamycin | 2001 |
Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities
Topics: 4-Quinolones; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Aza Compounds; Erythromycin; Fluoroquinolones; Gatifloxacin; Humans; Hydrogen-Ion Concentration; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycoplasma hominis; Mycoplasma pneumoniae; Oxazolidinones; Quinolines; Tetracyclines; Tigecycline; Ureaplasma urealyticum; Virginiamycin | 2001 |
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Phenotype; Streptococcal Infections; Streptococcus pyogenes; Taiwan; Virginiamycin | 2003 |
Sequence and genetic organization of the 19.3-kb erythromycin- and dalfopristin-resistance plasmid pLME300 from Lactobacillus fermentum ROT1.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; DNA Replication; DNA Restriction-Modification Enzymes; Drug Resistance, Multiple, Bacterial; Enterococcus; Erythromycin; Food Chain; Gene Order; Lactobacillus; Molecular Sequence Data; Open Reading Frames; Plasmids; Replication Origin; Sequence Analysis, DNA; Virginiamycin | 2003 |
In vitro synergistic effect of retapamulin with erythromycin and quinupristin against Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Humans; Macrolides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pyogenes; Virginiamycin | 2020 |